Subcellular Organelle Targeting as a Novel Approach to Combat Tumor Metastasis

Zefan Liu1, Yang Liu1, Xin Kang1

  • 1Department of General Surgery, First People's Hospital of Shuangliu District (West China Airport Hospital of Sichuan University), Chengdu 610200, China.

Pharmaceutics
|February 26, 2025
PubMed

Insights

Targeting subcellular organelles involved in tumor metastasis offers a new strategy for cancer therapy. This review explores organelle-specific delivery methods to enhance drug efficacy and reduce side effects in treating cancer spread.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Tumor metastasis is a complex process involving cancer cell spread to distant organs.
  • Subcellular organelles undergo significant changes during metastasis, impacting cancer progression.
  • Targeting these organelles presents a precise therapeutic strategy to improve drug delivery and efficacy.

Purpose of the Study:

  • To review the intricate relationship between tumor metastasis and subcellular organelles.
  • To elucidate organelle-specific targeting strategies for anti-metastasis therapies.
  • To discuss future prospects in organelle-targeted metastasis treatment.

Main Methods:

  • Comprehensive literature review of tumor metastasis mechanisms.
  • Analysis of subcellular organelle functions in cancer spread.
  • Evaluation of various targeting strategies for organelle delivery.

Main Results:

  • Subcellular organelles play a critical role in multiple stages of tumor metastasis.
  • Diverse targeting strategies, including biomembranes and peptides, are being developed for organelle delivery.
  • Precision targeting enhances therapeutic potency and minimizes off-target effects.

Conclusions:

  • Organelle-targeted therapies hold significant promise for improving cancer metastasis treatment.
  • Understanding organelle roles allows for multi-stage disruption of the metastatic cascade.
  • Further research into targeting strategies can lead to more effective anti-cancer drugs.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.3K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K